HEARTMATE 3 LVAS IMPLANT KIT
Report
- Report Number
- 2916596-2022-13689
- Event Type
- Injury
- Date Received
- September 9, 2022
- Date of Event
- December 1, 2020
- Report Date
- September 9, 2022
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- UDI-DI
- 00813024013297
- PMA / PMN Number
- P160054
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
THIS EVENT WAS ORIGINALLY REPORTED UNDER MFR# 2916596-2022-01919 AS PART OF A HISTORICAL JMACS PATIENT REGISTRY REVIEW IN JAPAN THROUGH MCS ABBOTT JAPAN AFFILIATE. ON 06SEP2022 THE REVIEW OF FILES OF THIS EVENT TYPE WAS COMPLETED. MANUFACTURE¿S INVESTIGATION CONCLUSION: A DIRECT CORRELATION BETWEEN HEARTMATE 3 LEFT VENTRICULAR ASSIST DEVICE (LVAD), SERIAL NUMBER (B)(4), AND THE REPORT OF RIGHT HEART FAILURE COULD NOT BE CONCLUSIVELY DETERMINED THROUGH THIS EVALUATION. IT WAS COMMUNICATED THAT THE PATIENT WAS READMITTED FROM (B)(6) 2020 TO (B)(6) 2020 DUE TO EXACERBATION OF RIGHT HEART FAILURE SYMPTOMS. A CARDIAC CATHERIZATION AND ADDITIONAL TESTING WERE PERFORMED. THE PATIENT'S ORAL MEDICATION WAS ADJUSTED AND PUMP SPEED WAS INCREASED. THE PATIENT REMAINS ONGOING ON (B)(4). NO ADDITIONAL RELATED EVENTS HAVE BEEN REPORTED AT THIS TIME. THE CURRENT HEARTMATE 3 LVAS IFU LIST RIGHT HEART FAILURE AS AN ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF THE HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM, "INTRODUCTION." ADDITIONALLY, ¿PATIENT CARE AND MANAGEMENT¿ LISTS RIGHT HEART FAILURE AS A POTENTIAL RISK/ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF HEARTMATE 3 LVAS. (UNDER ¿RIGHT HEART FAILURE¿) ALSO OUTLINES INDICATIONS OF RIGHT HEART FAILURE, AS WELL AS POSSIBLE TREATMENTS. THE RELEVANT SECTIONS OF THE DEVICE HISTORY RECORDS FOR (B)(4) WERE REVIEWED AND SHOWED NO DEVIATIONS FROM MANUFACTURING OR QUALITY ASSURANCE SPECIFICATIONS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.
IT WAS REPORTED THAT ON (B)(6) 2020 THE PATIENT WAS READMITTED DUE TO EXACERBATION OF RIGHT HEART FAILURE SYMPTOMS FROM (B)(6) 2020 TO (B)(6) 2020. THE PATIENT RECEIVED A CARDIAC CATHERIZATION, LAMP TEST AND ORAL ADJUSTMENT. THE SPEED OF THE PUMP WAS ADJUSTED. THE RELATIONSHIP BETWEEN THE EXACERBATION OF RIGHT HEART FAILURE SYMPTOMS AND THIS PRODUCT WAS UNKNOWN.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1579199 | HEARTMATE 3 LVAS IMPLANT KIT | VENTRICULAR (ASSIST) BYPASS | DSQ | THORATEC CORPORATION | 106524US | 7319416 | 00813024013297 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 40 YR | Male | Required Intervention| H |